Biological E seeks DCGI emergency use nod for Corbevax as booster in adults vaccinated with Covaxin, Covishield Ruchika Sharma12 May 2022 1:40 PM ISTAccording to the EUA application submitted to DCGI, Biological E in a phase-3 placebo-controlled clinical study, based on the drug regulator's nod,...
Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial for 2-18 age group Ruchika Sharma5 May 2022 12:34 PM ISTThe study is likely to be conducted at six sites, including AIIMS Delhi and Patna.
SC finds no haste in granting EUA to covishield, covaxin MD Bureau3 May 2022 1:08 PM ISTThe bench said: "The material provided by the Union of India, comprising minutes of the meetings of the SEC, do not warrant the conclusion that...
Bharat Biotech must address WHO's Covaxin suspension to avoid emergency use approval cancellation: MEA Ruchika Sharma29 April 2022 10:00 AM ISTThe communication stated that a proper response or policy from the government needs to be formulated on the issue and on further pursuance of...
DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for children Dr. Nandita Mohan27 April 2022 5:43 PM ISTThe Drugs Controller General of India (DCGI) on Tuesday approved three Covid vaccines for the restricted emergency use authorisation (EUA) for...
Health Bulletin 27/April/2022 Dr. Nandita Mohan27 April 2022 4:58 PM ISTHere are the top health stories for the day :NMC denies permission to 3 Medical Colleges, 550 MBBS seats lostFinding major deficiencies in three major...
Coronavirus vaccine: DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for different age group of children MD Bureau26 April 2022 5:00 PM ISTDCGI approved restricted use for emergency situation to ZycovD for children above the age of 12 years for a two-dose regimen.
Biological E gets CDSCO panel nod for Corbevax EUA for 5-11 years old Ruchika Sharma22 April 2022 1:10 PM ISTBiological E's Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years.
Bharat Biotech partner Ocugen to commercialize Covaxin in Mexico Ruchika Sharma19 April 2022 12:51 PM ISTAs a whole virion, inactivated vaccine, it elicits robust cellular immune memory to SARS-CoV-2 and variants of concern.
Setback to Bharat Biotech: USFDA places clinical hold on Covaxin trials Ruchika Sharma14 April 2022 1:00 PM ISTCovaxin, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) -...
Price reduction: Bharat Biotech Covaxin price slashed to Rs 225 per dose MD Bureau11 April 2022 12:34 PM ISTCovaxin will now cost Rs 225 per dose at private hospitals, from Rs 1,200 earlier.
Study says Bharat Biotech Covaxin booster enhances antibody response against COVID variants including Omicron Ruchika Sharma10 April 2022 11:30 AM IST"The data emphasises the need for speedup of the booster doses to individuals for dealing with emerging VOCs and its outcome to protect against death,...
